Skip to main content
P

Parmax Pharma Limited — Investor Relations & Filings

Ticker · 540359 ISIN · INE240T01014 LEI · 335800838LWBPQU5MJ05 BSE.NS Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country IN India
Listing BSE.NS 540359

About Parmax Pharma Limited

https://www.parmaxpharma.com/

Parmax Pharma Limited specializes in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical formulations. The company’s product range encompasses various delivery systems, including solid orals like tablets and capsules, as well as liquid preparations and topical ointments. Its therapeutic focus spans several categories, such as anti-infectives, analgesics, gastrointestinal agents, and respiratory medications. The organization maintains a commitment to stringent quality control measures and adheres to Good Manufacturing Practices (GMP) to ensure product safety and therapeutic effectiveness. By leveraging advanced production facilities and a comprehensive distribution infrastructure, the company provides healthcare solutions across multiple markets. Its core operations prioritize formulation research and the scaling of manufacturing processes to meet diverse clinical requirements.

Recent filings

No filings indexed yet

We are still gathering filings for Parmax Pharma Limited. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.